AcouSort AB (FRA:4SA) Other Current Receivables: €0.39 Mil (As of Mar. 2026)


FRA:4SA AcouSort AB FRA:4SA
50 GF Score
Price €0.33
GF Value €0.80
! 4 Warning Signs
View Full Analysis

What is AcouSort AB Other Current Receivables?

AcouSort AB FRA:4SA +0.31% 50 Other Current Receivables is €0.39 Mil as of Mar. 2026. GuruFocus rates FRA:4SA with a GF Score™ of 50/100 and a GF Value™ of €0.80. The stock has 4 warning signs investors should review.

AcouSort AB's Other Current Receivables for the quarter that ended in Mar. 2026 was €0.39 Mil.

AcouSort AB's quarterly Other Current Receivables increased from Sep. 2025 (€0.24 Mil) to Dec. 2025 (€0.37 Mil) and increased from Dec. 2025 (€0.37 Mil) to Mar. 2026 (€0.39 Mil).

AcouSort AB's annual Other Current Receivables increased from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€0.14 Mil) and increased from Dec. 2024 (€0.14 Mil) to Dec. 2025 (€0.37 Mil).

AcouSort AB Other Current Receivables Related Terms

AcouSort AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for AcouSort AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AcouSort AB Other Current Receivables Chart

AcouSort AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.10 0.12 0.14 0.37

AcouSort AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.20 0.24 0.37 0.39
FRA:4SA
50GF Score
AcouSort AB FRA:4SA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AcouSort AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.39 Mil mean?
AcouSort AB (FRA:4SA) has a Other Current Receivables of €0.39 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AcouSort AB and its competitors.
Is AcouSort AB's Other Current Receivables too high?
AcouSort AB's current Other Current Receivables is €0.39 Mil. Overall, AcouSort AB has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does AcouSort AB's Other Current Receivables compare to VRTX and REGN?
AcouSort AB's Other Current Receivables of €0.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AcouSort AB and its competitors. AcouSort AB's current Other Current Receivables is €0.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcouSort AB stock overvalued right now?
AcouSort AB (FRA:4SA) has a current Other Current Receivables of €0.39 Mil. The stock's GF Value™ is €0.80, compared to a current price of €0.33 — trading 59.3% below its estimated fair value. The current Other Current Receivables is €0.39 Mil. AcouSort AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For AcouSort AB (FRA:4SA), the current Other Current Receivables is €0.39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AcouSort AB (FRA:4SA) Overvalued in 2026?

Based on GuruFocus' analysis, AcouSort AB stock appears to be undervalued. The current stock price of €0.33 is trading 59.3% below its estimated GF Value™ of €0.80.

Key valuation signals for FRA:4SA:

  • Other Current Receivables: €0.39 Mil
  • GF Value™: €0.80 vs. price of €0.33 (59.3% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the FRA:4SA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AcouSort AB Business Description

Other Exchanges ACOU:Sweden
Address Medicon Village, Building 406, Lund, SWE, SE-223 81
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products includes AcouTrap, AcouWash, and AcouPlasma.
50GF Score

Get the complete analysis for FRA:4SA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price
€0.80
GF Value